Menu

Blog

Sep 19, 2021

New colon cancer study suggests Mirati has the best KRAS-blocking drug

Posted by in category: biotech/medical

With new colon cancer study results, Mirati lays claim to best KRAS-blocking drug.


The results are the strongest yet for a new class of cancer drugs that work by blocking the effects of a type of KRAS alteration called G12C.

Leave a reply